Perceptive Advisors as of March 31, 2020
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 111 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iovance Biotherapeutics (IOVA) | 9.7 | $349M | 12M | 29.93 | |
| Global Blood Therapeutics In | 8.6 | $310M | 6.1M | 51.09 | |
| Neurocrine Biosciences (NBIX) | 7.4 | $265M | 3.1M | 86.55 | |
| Amicus Therapeutics (FOLD) | 6.5 | $233M | 25M | 9.24 | |
| Bridgebio Pharma (BBIO) | 5.4 | $195M | 6.7M | 29.00 | |
| Kodiak Sciences (KOD) | 4.9 | $175M | 3.7M | 47.70 | |
| Zymeworks | 3.5 | $126M | 3.6M | 35.41 | |
| Nevro (NVRO) | 3.0 | $107M | 1.1M | 98.39 | |
| Springworks Therapeutics (SWTX) | 2.6 | $94M | 3.5M | 27.00 | |
| Zogenix | 2.6 | $93M | 3.8M | 24.73 | |
| Athenex | 2.5 | $89M | 12M | 7.74 | |
| Meiragtx Holdings (MGTX) | 2.4 | $87M | 6.4M | 13.44 | |
| Kadmon Hldgs | 1.8 | $66M | 16M | 4.19 | |
| Myokardia | 1.7 | $62M | 1.3M | 46.88 | |
| Frequency Therapeutics | 1.5 | $54M | 3.0M | 17.81 | |
| Quotient | 1.5 | $53M | 13M | 3.95 | |
| Adma Biologics (ADMA) | 1.3 | $48M | 12M | 4.15 | |
| Vbi Vaccines | 1.2 | $44M | 46M | 0.95 | |
| Retrophin | 1.2 | $42M | 2.9M | 14.59 | |
| Blueprint Medicines (BPMC) | 1.1 | $40M | 689k | 58.48 | |
| Regeneron Pharmaceuticals (REGN) | 1.1 | $39M | 80k | 488.29 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.1 | $38M | 2.6M | 14.70 | |
| Verrica Pharmaceuticals | 1.0 | $37M | 3.4M | 10.93 | |
| Retrophin Inc note 2.500% 9/1 | 1.0 | $35M | 45M | 0.78 | |
| Eidos Therapeutics | 0.9 | $34M | 687k | 48.99 | |
| Molecular Templates | 0.9 | $33M | 2.5M | 13.29 | |
| Albireo Pharma | 0.9 | $32M | 2.0M | 16.29 | |
| Agios Pharmaceuticals (AGIO) | 0.9 | $32M | 900k | 35.40 | |
| Vapotherm | 0.9 | $31M | 1.7M | 18.83 | |
| Rocket Pharmaceuticals (RCKT) | 0.8 | $31M | 2.2M | 13.95 | |
| Allogene Therapeutics (ALLO) | 0.8 | $30M | 1.5M | 19.44 | |
| Agile Therapeutics | 0.8 | $30M | 16M | 1.86 | |
| Dbv Technologies S A | 0.8 | $29M | 7.3M | 3.92 | |
| Arena Pharmaceuticals | 0.8 | $28M | 675k | 42.00 | |
| Provention Bio | 0.8 | $28M | 3.0M | 9.20 | |
| Black Diamond Therapeutics (BDTX) | 0.8 | $28M | 1.1M | 24.95 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.7 | $25M | 1.6M | 16.33 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $25M | 3.3M | 7.67 | |
| Theravance Biopharma (TBPH) | 0.6 | $23M | 1.0M | 23.11 | |
| Urovant Sciences | 0.6 | $22M | 2.4M | 9.22 | |
| Concert Pharmaceuticals I equity | 0.5 | $20M | 2.2M | 9.09 | |
| Menlo Therapeutics | 0.5 | $18M | 6.6M | 2.63 | |
| Regenxbio Inc equity us cm (RGNX) | 0.5 | $17M | 508k | 33.75 | |
| Solid Biosciences | 0.4 | $16M | 6.7M | 2.39 | |
| Neptune Wellness Solutions I | 0.4 | $16M | 13M | 1.17 | |
| Turning Point Therapeutics I | 0.4 | $15M | 350k | 44.13 | |
| Stoke Therapeutics (STOK) | 0.4 | $15M | 672k | 22.90 | |
| Denali Therapeutics (DNLI) | 0.4 | $15M | 850k | 17.51 | |
| 10x Genomics Inc Cl A (TXG) | 0.4 | $14M | 220k | 62.80 | |
| Insulet Corporation (PODD) | 0.4 | $14M | 83k | 165.69 | |
| Revance Therapeutics | 0.4 | $14M | 925k | 14.80 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.4 | $13M | 495k | 27.12 | |
| Establishment Labs Holdings Ord (ESTA) | 0.4 | $13M | 923k | 14.45 | |
| Alector (ALEC) | 0.3 | $12M | 512k | 24.13 | |
| Y Mabs Therapeutics | 0.3 | $12M | 523k | 23.13 | |
| Gilead Sciences (GILD) | 0.3 | $11M | 1.5M | 7.48 | |
| Leap Therapeutics | 0.3 | $11M | 6.7M | 1.58 | |
| Schrodinger (SDGR) | 0.3 | $11M | 250k | 42.18 | |
| Twist Bioscience Corp (TWST) | 0.3 | $10M | 322k | 32.20 | |
| Vocera Communications | 0.3 | $10M | 470k | 21.91 | |
| AtriCure (ATRC) | 0.3 | $10M | 302k | 33.59 | |
| Sc Health Corp unit 99/99/9999 | 0.3 | $10M | 1.0M | 10.00 | |
| Morphic Hldg (MORF) | 0.3 | $9.5M | 650k | 14.68 | |
| Health Catalyst (HCAT) | 0.2 | $8.4M | 329k | 25.48 | |
| Revolution Medicines (RVMD) | 0.2 | $7.8M | 350k | 22.33 | |
| Aldeyra Therapeutics (ALDX) | 0.2 | $7.6M | 3.1M | 2.47 | |
| Immunovant Inc unit 12/18/2024 (IMVTU) | 0.2 | $7.4M | 400k | 18.39 | |
| Fulcrum Therapeutics (FULC) | 0.2 | $7.2M | 600k | 11.94 | |
| Anaptysbio Inc Common (ANAB) | 0.2 | $7.1M | 500k | 14.14 | |
| Cerner Corporation | 0.2 | $6.7M | 105k | 64.24 | |
| Silk Road Medical Inc Common | 0.2 | $6.6M | 205k | 32.45 | |
| Mylan Nv | 0.2 | $6.0M | 400k | 15.07 | |
| Viewray (VRAYQ) | 0.2 | $5.7M | 2.5M | 2.33 | |
| Neoleukin Therapeutics | 0.2 | $5.5M | 500k | 11.07 | |
| Female Health (VERU) | 0.2 | $5.4M | 1.7M | 3.27 | |
| Mirati Therapeutics | 0.1 | $5.1M | 3.4M | 1.49 | |
| Translate Bio | 0.1 | $5.0M | 435k | 11.48 | |
| Zimmer Holdings (ZBH) | 0.1 | $4.9M | 50k | 98.28 | |
| Mei Pharma | 0.1 | $4.9M | 3.0M | 1.61 | |
| Iveric Bio | 0.1 | $4.7M | 1.4M | 3.44 | |
| Ideaya Biosciences (IDYA) | 0.1 | $4.7M | 1.1M | 4.12 | |
| Aquestive Therapeutics | 0.1 | $3.8M | 1.8M | 2.19 | |
| 1life Healthcare | 0.1 | $3.3M | 185k | 17.89 | |
| Dermtech Ord ord (DMTKQ) | 0.1 | $3.2M | 286k | 11.25 | |
| Galera Therapeutics (GRTX) | 0.1 | $3.1M | 325k | 9.50 | |
| Abeona Therapeutics | 0.1 | $3.1M | 1.5M | 2.04 | |
| Lifesci Acquisition Corp unit 03/31/2025 | 0.1 | $2.9M | 300k | 9.80 | |
| Motus Gi Hldgs Incorporated | 0.1 | $2.8M | 4.2M | 0.67 | |
| Rhythm Pharmaceuticals (RYTM) | 0.1 | $2.6M | 171k | 15.22 | |
| Alphatec Holdings (ATEC) | 0.1 | $2.0M | 562k | 3.60 | |
| Phreesia (PHR) | 0.0 | $1.4M | 70k | 20.34 | |
| Bio-Rad Laboratories (BIO) | 0.0 | $1.2M | 3.5k | 349.10 | |
| Axonics Modulation Technolog (AXNX) | 0.0 | $1.2M | 50k | 23.76 | |
| Therapeuticsmd | 0.0 | $1.2M | 1.1M | 1.07 | |
| Ferrari Nv Ord (RACE) | 0.0 | $957k | 6.2k | 154.35 | |
| Eiger Biopharmaceuticals | 0.0 | $951k | 140k | 6.80 | |
| Momenta Pharmaceuticals | 0.0 | $881k | 31k | 28.76 | |
| Sierra Oncology | 0.0 | $664k | 67k | 9.96 | |
| Acceleron Pharma | 0.0 | $583k | 6.8k | 85.57 | |
| Repro-Med Systems (KRMD) | 0.0 | $537k | 75k | 7.18 | |
| Luminex Corp | 0.0 | $500k | 19k | 26.42 | |
| Karuna Therapeutics Ord | 0.0 | $497k | 6.9k | 71.57 | |
| Chemocentryx | 0.0 | $406k | 10k | 39.60 | |
| Cue Biopharma (CUE) | 0.0 | $362k | 26k | 13.73 | |
| Apellis Pharmaceuticals (APLS) | 0.0 | $327k | 11k | 28.64 | |
| Mereo Biopharma Group Plc ads (MREO) | 0.0 | $187k | 179k | 1.04 | |
| Artara Therapeutics | 0.0 | $184k | 8.5k | 21.54 | |
| Spdr S&p 500 Etf (SPY) | 0.0 | $159k | 325k | 0.49 | |
| Flamel Technologies Sa | 0.0 | $76k | 8.7k | 8.75 | |
| Outlook Therapeutics Inc *w exp 02/18/201 | 0.0 | $46k | 421k | 0.11 | |
| Restorbio | 0.0 | $10k | 9.3k | 1.07 |